SCHEMBL7600153

SCHEMBL7600153

CCOC(=O)c1ccc(NC(=O)c2ccc3c(c2)C(c2cccs2)=CCC3(C)C)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARA P10276 9/20 0.77
RARB P10826 7/20 0.77
RARG P13631 6/20 0.58
RAB9A P51151 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
NPC1 O15118 3/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 6/20 0.46
TSHR P16473 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
RXFP1 Q9HBX9 2/20 0.45
TP53 P04637 1/20 0.45
MAPK1 P28482 3/20 0.44
ALDH1A1 P00352 2/20 0.44
MEN1 O00255 1/20 0.44
CASP3 P42574 1/20 0.44
KMT2A Q03164 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8981624 0.87 RARA (1.00) RARARARBRARGTSHRMAPK1
SCHEMBL6297253 0.85 RARA (0.79) RARARARBRARGGAAMAPT
SCHEMBL6292455 0.84 RARA (0.58) RARARARBRARGRAB9ASMN1; SMN2
SCHEMBL6292454 0.84 RARA (0.58) RARARARBRARGRAB9ASMN1; SMN2
SCHEMBL6234703 0.84 RARA (0.76) RARARARBRARGKMT2A
SCHEMBL6232866 0.83 RARA (0.77) RARARARBRARGRAB9ASMN1; SMN2
SCHEMBL27574949 0.81 RARA (0.55) RARARARBRARGRAB9ANPC1
SCHEMBL6293907 0.81 RARB (0.74) RARARARBRARGRAB9ANPC1
SCHEMBL27461633 0.80 RARA (0.64) RARARARBRARGRAB9ASMN1; SMN2
SCHEMBL6294092 0.79 RARA (0.52) RARARARBRARGRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020099038-A1 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity ALLERGAN, INC. 2002-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020099038-A1 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity RARB, RARA, RXRB RARA 2/4885RARB 1/4885RARG 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.